Table 3.
MNI coordinates for the peak of activity in regions activated for No-Go false alarms compared to implicit baseline in FHN and FHP individuals after administration of memantine or placebo
Region (BA) | Left hemisphere |
FHN—effect of memantine |
FHP—effect of memantine |
Right hemisphere |
FHN—effect of memantine |
FHP—effect of memantine |
---|---|---|---|---|---|---|
Superior frontal gyrus (10/9) | −30, 48, 18 | ↓ | 27, 54, 18 | |||
Supplementary motor area (6/8) | −3, 15, 51 | ↓ | 3, 15, 51 | ↓ | ||
Middle frontal gyrus (10) | −33, 39, 18 | ↓ | 39, 42, 15 | |||
Inferior frontal gyrus (47) | −39, 18, −6 | 39, 18, −6 | ||||
Anterior cingulate (32) | −6, 27, 33 | ↓ | 6, 30, 27 | |||
Precentral gyrus (6) | −42, −15, 51 | 24, −18, 57 | ||||
Insula | −42, 9, −9 | ↓ | 39, 15, 0 | |||
Thalamus | −12, −15, 0 | 12, −6, −3 | ||||
Putamen | −18, 12, 3 | ↓ | 18, 6, 3 | ↓ | ||
Caudate | −15, 9, 12 | ↓ | 15, 9, 3 | ↓ | ||
Subthalamic nucleus | −9, −15, −6 | 12, −15, −6 | ||||
Parahippocampal gyrus | −9, −33, −3 | 12, −33, −3 | ||||
Superior parietal lobule (7) | −30, −57, 54 | ↓ | 27, −66, 51 | ↓ | ||
Precuneus (7) | −6, −51, 51 | ↓ | 15, −66, 54 | ↓ | ||
Inferior parietal lobule (40) | −63, −42, 21 | 60, −51, 27 | ||||
Posterior cingulate (30) | −21, −69, 3 | ↓ | 0, −24, 27 | ↓ | ||
Superior temporal gyrus (42/22/38) | −45, 12, −15, | 45, 12, −15 | ↓ | ↓ | ||
Middle temporal gyrus (21/39) | −57, −27, −9 | 60, −27, −12 | ||||
Inferior temporal gyrus (37) | −51, −72−6 | ↓ | 54,−72, −6 | |||
Fusiform gyrus (37) | −42, −48, −21 | ↓ | 42, −54, −24 | |||
Lingual gyrus (18) | −12, −72, 0 | ↓ | 18, −66, 0 | |||
Cuneus (18) | −12, −75, 9 | 18, −69, 6 | ||||
Culmen | −30, −57, −30 | 30, −57, −30 | ↓ | |||
Cerebellum crus 1 | −42, −57, −27 | 42, −57, −27 | ||||
Tonsil | −36, −57, −45 | 36, −57, −42 | ↓ | |||
Vermis | −3, −69, −9 | ↓ | 3, −9, −15 |
Regions activated for No-Go correct rejects >baseline across groups during placebo. Only variables showing significant experimental effects are shown, thus FHP vs. FHN placebo for both hemispheres is not shown. A downward arrow represents a reduction in activity during memantine challenge vs. placebo, an upward arrow represents an increased in activity during memantine challenge vs. placebo